Clinical Trial Update: Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cadonilimab in combination with chemotherapy for recurrent or refractory pleural mesothelioma; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Mesothelioma

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Pleural Mesothelioma | Phase 2 | Status: NOT_YET_RECRUITING